Reference drug

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

AdultStatin

120 competitors in Adult

#DrugCompanyPhaseTrials

1

Nydrazid

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 3

12

Tebrazid

AAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Phase 3

13

Mounjaro

Eli Lilly

Phase 2

14

Rifampicin

Boehringer Ingelheim

Phase 3

35

Opzelura

DDizal Pharmaceuticals

Phase 2

16

NM8074

NNovelMed Therapeutics

Phase 2

27

Hytrin

AAbbott

Phase 1

18

Ansaid

PPharmacia and Upjohn

Phase 1

19

Augtyro

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 1

110

CAB LA

GSK

Phase 1

1Show 26 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

CKD5 trials

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389

Unknown status·Chong Kun Dang Pharmaceutical·Phase 1·NCT04322032·34 enrolled

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

Unknown status·Chong Kun Dang Pharmaceutical·Phase 1·NCT04651881·24 enrolled

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

Completed·Chong Kun Dang Pharmaceutical·Phase 1·NCT04075643·52 enrolled

Show 2 more trials

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)

Completed·Chong Kun Dang Pharmaceutical·Phase 1·NCT04083872·16 enrolled

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)

Completed·Chong Kun Dang Pharmaceutical·Phase 1·NCT04083846·24 enrolled

Adult2 trials

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults

Completed·AAJU Pharm Co., Ltd.·Phase 1·NCT06931327·60 enrolled

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

Active, not recruiting·AAJU Pharm Co., Ltd.·Phase 1·NCT06933459·60 enrolled

Randomized1 trial

A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers

Completed·Pfizer··NCT01677065·14 enrolled

MPA1 trial

A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability

Completed·LLG Chem·Phase 1·NCT06743997·48 enrolled

Statin1 trial

Bioequivalence Study of Rosuvastatin Tablet

Completed·UUniversity of Karachi·N/A·NCT05637060·36 enrolled

10 more indications

Female1 trial

A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.

Completed·Pfizer·Phase 1·NCT01260805·32 enrolled

Pilot Study1 trial

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

Recruiting·Chong Kun Dang Pharmaceutical·Phase 2·NCT06954766·100 enrolled

Fasting Conditions1 trial

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

Unknown status·Chong Kun Dang Pharmaceutical·Phase 1·NCT04678388·24 enrolled

Hypertension1 trial

A Randomized, Open-Label, Fasting, 2-Period, 2-Sequence Crossover Study to Evaluate the Bioequivalence and Safety of AJU-C719 and C719R in Healthy Adult Volunteers

Not yet recruiting·AAJU Pharm Co., Ltd.·Phase 1·NCT07901114·60 enrolled

Peripheral Arterial Disease1 trial

A Randomized, Open-Label, Fasting, Single-Dose, Oral, 2-Group, 4-Period, Replicate Crossover Study to Evaluate the Bioequivalence and Safety of AJU-B718 and B718R in Healthy Adult Volunteers

Not yet recruiting·AAJU Pharm Co., Ltd.·Phase 1·NCT07901088·40 enrolled

Benign Prostatic Hyperplasia (BPH)1 trial

An Open-Label, Randomized, Fasting, Single-Dose, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of "AJU-G721" and "G721R" in Healthy Adult Male Subjects

Completed·AAJU Pharm Co., Ltd.·Phase 1·NCT07643220·45 enrolled

Hypercholerolemia1 trial

An Open-Label, Randomized, Fasting, Single-Dose, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of "AJU-C715" and "C715R" in Healthy Adult Volunteers

Completed·AAJU Pharm Co., Ltd.·Phase 1·NCT07581028·61 enrolled

Retinal Vein Occlusion1 trial

A Multicenter, Randomized, Double-blind, Parallel Design, Active-controlled Phase 3 Study to Determine Efficacy and Safety Following Administration of SMO1 in Patients With Retinal Vein Occlusive Macular Edema

Recruiting·SSANGMYUNG innovation·Phase 3·NCT07708142·312 enrolled

Hypercholesterolemia1 trial

An Open Label, Randomized, Single Dose, 2-sequence, 2-period, Cross-over to Evaluate the Safety and Pharmacokinetics of AJU-C716 Compared to C716R in Healthy Adult Volunteers

Completed·AAJU Pharm Co., Ltd.·Phase 1·NCT07655960·41 enrolled

Unspecified1 trial

Diflucan Bioequivalence Study For Transferring The Manufacture

Completed·Pfizer·Phase 1·NCT03821480·28 enrolled

Details

Drug Info

Related News